Taysha Gene Therapies (TSHA) Free Cash Flow (2020 - 2026)
Taysha Gene Therapies (TSHA) free cash flow from Mar 31, 2020 to Mar 31, 2026. The TTM Taysha Gene Therapies (TSHA) free cash flow is -$113M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Taysha Gene Therapies (TSHA) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +34.69% |
| 3 Years TTM | +10.36% |
| 5 Years TTM | +16.88% |
| All Time TTM | +16.88% |
Annual Free Cash Flow change of Taysha Gene Therapies (TSHA)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$41M | -56.41% |
| 2025 | -$94M | +15.00% |
| 2024 | -$82M | +6.11% |
| 2023 | -$77M | -29.47% |
| 2022 | -$109M | -17.63% |
| 2021 | -$132M | +329.54% |
| 2020 | -$31M | N/A |
Comparison Taysha Gene Therapies (TSHA) five years free cash flow CAGR with competitors
Taysha Gene Therapies (TSHA) five years free cash flow CAGR is 16.88%.